Your cart is currently empty!
Category: Human Immunodeficiency Virus (HIV-1)
Efavirenz+Emtricitabine+Tenofovir Disoproxil Fumarate
Description
This page contains brief details about the drug efavirenz,emtricitabine,tenofovir disoproxil fumarate, it’s indication, dosage & administaration, mechanism of action, related brands with strength, warnings and common side effects.
Date of Approval
Efavirenz, Emtricitabine and Tenofovir disoproxil Fumarate is a complete regimen consisting of antiviral medications, which was approved for its medical use on 12th July 2006.
Mechanism of Action of Efavirenz+Emtricitabine+Tenofovir Disoproxil Fumarate
Efavirenz, Emtricitabine and Tenofovir disoproxil Fumarate Tablet is a combination of non-nucleoside reverse transcriptase inhibitor, nucleoside reverse transcriptase inhibitor and nucleotide reverse transcriptase inhibitors. It works by increasing the number of CD4 T cells and stimulates the immune system to fight against infections. Thereby, it reduces the viral load of HIV in the blood and decreases the severity of HIV infection.
Uses of Efavirenz+Emtricitabine+Tenofovir Disoproxil Fumarate
Efavirenz, Emtricitabine and Tenofovir disoproxil Fumarate is indicated as a complete regimen to treat human immunodeficiency virus infection in adults and paediatric patients older than 12 years of age.
Efavirenz+Emtricitabine+Tenofovir Disoproxil Fumarate Dosage available Efavirenz, Emtricitabine and Tenofovir disoproxil fumarate is available as film coated tablets consisting of 600mg of Efavirenz, 200mg of Emtricitabine and 300mg of Tenofovir disoproxil fumarate. The usual recommended dosage of this combination regimen is one tablet every day, preferably at bedtime.
Emtricitabine+Tenofovir Alafenamide
Description
This page contains brief details about the drug emtricitabine,tenofovir alafenamide, it’s indication, dosage & administaration, mechanism of action, related brands with strength, warnings and common side effects.
Date of Approval
Emtricitabine + Tenofovir alafenamide is a combination of anti-retroviral drug. Emtricitabine belongs to the class of medication called nucleoside reverse transcriptase inhibitor (NRTI), and Tenofovir alafenamide belongs to the class called nucleotide reverse transcriptase inhibitor (NtRTI). FDA approved it initially in September 2015 for its medical use.
Mechanism of Action of Emtricitabine+Tenofovir Alafenamide
Emtricitabine and Tenofovir alafenamide are nucleoside/nucleotide analog reverse transcriptase inhibitors, exhibiting their antiviral effect by competing with natural substrates and incorporating them into viral DNA, resulting in the termination of the DNA chain.
Uses of Emtricitabine+Tenofovir Alafenamide
Emtricitabine+Tenofovir alafenamide is used in combination with other medicines to treat human immunodeficiency virus (HIV-1) infection in adults and adolescents 12 years of age and who weigh at least 35kg. They work by slowing the spread of HIV in the body.
Emtricitabine+Tenofovir Alafenamide Dosage available
It is an orally available prescription drug. Your doctor will decide the dose and duration of Emtricitabine+Tenofovir alafenamide based on the disease condition and other factors such as body weight and age. Always take this medicine as prescribed by your doctor. Take the tablet at the same time, with or without food. Do not break, chew, crush, or break the tablet. Swallow the whole tablet with a glass of water. If you have difficulty swallowing the tablet, you can split it in half after consulting with your doctor.
Darunavir + Ritonavir
Description
This page contains brief details about the drug darunavir,ritonavir, it’s indication, dosage & administaration, mechanism of action, related brands with strength, warnings and common side effects.
Date of Approval
Darunavir, Ritonavir is a combination regimen consisting of antiviral medications, which was approved for its medical use on 23rd June 2006.
Mechanism of Action of Darunavir + Ritonavir
Darunavir, Ritonavir Tablet is an antiviral combination of medicine that belongs to the category of protease inhibitors. The protease enzyme forms the final protein structure of the HIV. Darunavir and Ritonavir works by inhibiting the action of protease enzymes and leads to the formation of HIV proteins with poor morphology. This, in turn, stops the replication of the virus.
Uses of Darunavir + Ritonavir
Darunavir, Ritonavir has been developed to treat Human Immunodeficiency Virus (HIV-1). Darunavir, Ritonavir Tablet is indicated as a complete regimen for treating adults and children older than 3 years of age, infected with HIV 1.
Darunavir + Ritonavir Dosage available
Darunavir, Ritonavir is available as film coated tablets consisting of 600mg of Darunavir and 100mg of Ritonavir. The usual recommended dosage of this combination regimen is one tablet everyday with or without food.
Emtricitabine + Tenofovir
Description
This page contains brief details about the drug emtricitabine,tenofovir alafenamide, it’s indication, dosage & administaration, mechanism of action, related brands with strength, warnings and common side effects.
Date of Approval
Emtricitabine + Tenofovir alafenamide is a combination of anti-retroviral drug. Emtricitabine belongs to the class of medication called nucleoside reverse transcriptase inhibitor (NRTI), and Tenofovir alafenamide belongs to the class called nucleotide reverse transcriptase inhibitor (NtRTI). FDA approved it initially in September 2015 for its medical use.
Mechanism of Action of Ceftazidime & Avibactam
Emtricitabine and Tenofovir alafenamide are nucleoside/nucleotide analog reverse transcriptase inhibitors, exhibiting their antiviral effect by competing with natural substrates and incorporating them into viral DNA, resulting in the termination of the DNA chain.
Uses of Ceftazidime & Avibactam
Emtricitabine+Tenofovir alafenamide is used in combination with other medicines to treat human immunodeficiency virus (HIV-1) infection in adults and adolescents 12 years of age and who weigh at least 35kg. They work by slowing the spread of HIV in the body.
Ceftazidime & Avibactam Dosage available
It is an orally available prescription drug. Your doctor will decide the dose and duration of Emtricitabine+Tenofovir alafenamide based on the disease condition and other factors such as body weight and age. Always take this medicine as prescribed by your doctor. Take the tablet at the same time, with or without food. Do not break, chew, crush, or break the tablet. Swallow the whole tablet with a glass of water. If you have difficulty swallowing the tablet, you can split it in half after consulting with your doctor.
Abacavir,Dolutegravir,Lamivudine
Description
This page contains brief details about the drug abacavir,dolutegravir,lamivudine, it’s indication, dosage & administaration, mechanism of action, related brands with strength, warnings and common side effects.
Date of Approval
Abacavir, Dolutegravir and Lamivudine is a combination regimen consisting of antiviral medications, which was approved for its medical use on 22nd August 2014.
Mechanism of Action of Abacavir,Dolutegravir,Lamivudine
Abacavir, Dolutegravir and Lamivudine Tablet is a combination of integrase strand transfer inhibitors and nucleoside analog reverse transcriptase inhibitors. It works by increasing the number of CD4 T cells and stimulates the immune system to fight against infections. Abacavir and Lamivudine inhibit the reverse transcriptase enzyme of the HIV-1, induce chain termination, and prevents the incorporation of viral DNA. Thereby, it reduces the viral load of HIV in the blood and decreases the severity of HIV infection.
Uses of Abacavir,Dolutegravir,Lamivudine
Abacavir, Dolutegravir, and Lamivudine have been developed to treat Human Immunodeficiency Virus (HIV-1). Abacavir, Dolutegravir, and Lamivudine Tablet is indicated as a complete regimen for treating adults and children infected with HIV 1.
Abacavir,Dolutegravir,Lamivudine Dosage available Abacavir, Dolutegravir and Lamivudine is available as film-coated tablets and oral suspension. The tablets consist of 600mg of Abacavir, 50mg of Dolutegravir, and 300mg of Lamivudine. The usual recommended dosage of this combination regimen is one tablet every day with or without food.